Please login to the form below

Not currently logged in
Email:
Password:

South Asia

This page shows the latest South Asia news and features for those working in and with pharma, biotech and healthcare.

Asian patient groups give pharma above average marks for reputation

Asian patient groups give pharma above average marks for reputation

New data from PatientView’s established corporate reputation survey show 49% of patient groups in Asia believe the sector has an ‘excellent’or ‘good’corporate reputation. ... The figures, drawn from 98 patient groups from Australasia, Central

Latest news

More from news
Approximately 1 fully matching, plus 55 partially matching documents found.

Latest Intelligence

  • A new route to market A new route to market

    For example, in parts of Asia and the Middle East, business and personal friendships are often one and the same, meaning the importance of establishing relationships and connections cannot be underestimated. ... From Eastern Europe to North America and

  • Pharma deals in June 2015 Pharma deals in June 2015

    EU and other countries (ex North America, Mexico, JP/Asia). excluding Japan, South Korea, Taiwan, Israel.

  • Medius Deal Watch table for April 2015 Medius Deal Watch table for April 2015

    151. UCB/ Dr. Reddy's. Business acquisition. Dermatology, respiratory and paediatric products for South Asia. ... South Asia (India, Nepal, Sri Lanka and the Maldives) INR 800 Crores.

  • Pharma deals in April 2015 Pharma deals in April 2015

    Dr Reddy's, Menarini and Cipher Pharmaceuticals have acquired or licensed rights to products in South Asia, Asia Pacific (ex-Japan) and North America and Mexico, respectively. ... Previously rumoured, Dr Reddy's acquires rights to dermatology,

  • Pharma deals during September 2013 Pharma deals during September 2013

    This month's deals have strong international and regional flavours, with deals involving companies in across Europe, Africa, South America, US and Asia. ... GSK also received $700m from the sale of two thrombosis drugs (Arixtra and Fraxiparine), to Aspen

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest appointments

  • Philips names head of healthcare for South Asia Philips names head of healthcare for South Asia

    Philips names head of healthcare for South Asia. Sameer Garde takes role at tech company. ... The technology firm Philips has appointed Sameer Garde to lead its healthcare business in South Asia.

  • Havas Worldwide appoints healthcare head in SE Asia Havas Worldwide appoints healthcare head in SE Asia

    Havas Worldwide appoints healthcare head in SE Asia. Victor Joseph ‘ VJ’ Yamat is managing director of healthcare operations in emerging region. ... Havas Worldwide has promoted Victor Joseph 'VJ' Yamat as managing director of healthcare operations

  • Merck KGaA appoints new CFO Merck KGaA appoints new CFO

    His other roles included serving as regional general manager for Henkel's adhesive business in South East Asia, during which time he was involved in integrating the largest acquisitions in

  • Meeta Gulyani leaves Roche for Merck Serono Meeta Gulyani leaves Roche for Merck Serono

    Gulyani was general manager for South Asia at Roche but will now move to the US to head strategy and global franchises at Merck Serono, the pharma division of Merck KGaA.

  • Takeda promotes Giles Platford Takeda promotes Giles Platford

    Before joining Takeda, Platford spent eight years in the pharmaceutical industry in Asia Pacific, in various business development, commercial and general management roles. ... and South Asia. “

More from appointments
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 11 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Genetic Digital

We help healthcare, pharma & medical device organisations use web and mobile technologies to effectively connect patients and healthcare professionals....

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics